|
Post by brotherm1 on Apr 15, 2019 15:05:28 GMT -5
You’re both wrong. This guy’s deeply connected. You believe he’s not invested in MNKD and just writes these articles for $60 like he said on this board before he deleted all of his posts? If so there are many that would like to sell you some swamp land. His articles are always timely at times when he knows they can manipulate the share price. You think he knows all about MNKD competitors and competing drugs without the help of experts in the field helping him to write the articles? No one else writes near as much as this guy on MNKD. The share price consistently goes with his articles. No doubt he has deep connections controlling the share price He wants his agenda only. Notice comments on SA contrary to his articles are deleted Who cares what his agenda is. If management executed properly, there's not a damn thing SO could do about it. Instead, all these missteps just gives him more fodder to write on. There's no point blaming a random writer on a stock blog site for MannKind's underlying issues.
|
|
|
Post by hellodolly on Apr 15, 2019 15:05:51 GMT -5
You’re both wrong. This guy’s deeply connected. You believe he’s not invested in MNKD and just writes these articles for $60 like he said on this board before he deleted all of his posts? If so there are many that would like to sell you some swamp land. His articles are always timely at times when he knows they can manipulate the share price. You think he knows all about MNKD competitors and competing drugs without the help of experts in the field helping him to write the articles? No one else writes near as much as this guy on MNKD. The share price consistently goes with his articles. No doubt he has deep connections controlling the share price He wants his agenda only. Notice comments on SA contrary to his articles are deleted I think you support my argument with additional facts. He gets help, he's smart, he has the time and the funding but, it doesn't take much to declare that "Company A" will need further dilution because they're running out of cash by XYZ date (and then the out clause), "...unless they have some other trick up their sleeve or can pull a rabbit out of their hat" aka Partnership or other non-dilutive funding. I'll say it again, duh. Deeply connected to who? Hedge funds? BP? I did mention that he was funded, we just don't know by who? Hedge funds? BP? Fartstein has help, too. His degree in polysci surely didn't make him a guru on biotechs. He's stated before that he has doctors that take a look at his material and at results being published by biotechs. I think we are splitting hairs but essentially saying the same things.
|
|
|
Post by cretin11 on Apr 15, 2019 15:08:17 GMT -5
Let's not give SO more credit than he deserves. He doesn't manipulate share price. The share price has sucked for five years now, and SO's articles have been negative during that time. That isn't causation, it's just him calling out what is obvious, anybody can do that. His articles haven't been "timely when he knows they can manipulate share price" - to the contrary, the dude simply writes about MNKD constantly. And yes he does get weirdly personal with his rhetoric, and wouldn't be a surprise if he's being put up to it.
Management is being paid handsomely to execute, if they do that then SO will be proven wrong. That's what will help share price, not anything SO does or doesn't do.
|
|
|
Post by brotherm1 on Apr 15, 2019 15:08:32 GMT -5
Who cares what his agenda is. If management executed properly, there's not a damn thing SO could do about it. Instead, all these missteps just gives him more fodder to write on. There's no point blaming a random writer on a stock blog site for MannKind's underlying issues. Duhhh! Don’t you think it’s a bit difficult to execute properly and do what’s needed to grow when the share price is consistently manipulated down?!!!
|
|
|
Post by cretin11 on Apr 15, 2019 15:11:10 GMT -5
Yes "it's a bit difficult" but that's their job and it's not impossible. Especially when we have the best mealtime insulin available in the world today.
|
|
|
Post by awesomo on Apr 15, 2019 15:40:51 GMT -5
Duhhh! Don’t you think it’s a bit difficult to execute properly and do what’s needed to grow when the share price is consistently manipulated down?!!! We went up significantly on UTHR partnership and last quarter’s earnings call. In the long term, positive events move the stock upwards just like negative events push it down. If MannKind strung together multiple positive events, we would go up regardless of what SO is writing. Unfortunately, management just can’t seem to do this (ex. we followed UTHR up with good ole dilution).
|
|
|
Post by brotherm1 on Apr 15, 2019 15:47:24 GMT -5
Where can one learn about MNKD as a potential investment? Well, the NASDAQ website is logical place to start. And on there you just look under Fundamentals, click on Call Transcripts. From there just click on Summary and.....oh look! Check out all the Osborne negative articles about MNKD. How convenient!
|
|
|
Post by mytakeonit on Apr 15, 2019 16:00:14 GMT -5
Or, send $20 to mytakeonit.com
But, that's mytakeonit
|
|
|
Post by mannmade on Apr 15, 2019 16:10:09 GMT -5
Duhhh! Don’t you think it’s a bit difficult to execute properly and do what’s needed to grow when the share price is consistently manipulated down?!!! We went up significantly on UTHR partnership and last quarter’s earnings call. In the long term, positive events move the stock upwards just like negative events push it down. If MannKind strung together multiple positive events, we would go up regardless of what SO is writing. Unfortunately, management just can’t seem to do this (ex. we followed UTHR up with good ole dilution). Agree with you except that if the positive event is not associated with any reoccuring revenue then without subsequent events close enough in time for additional funds mnkd goes back down as the need for more funding starts to appear closer and closer as it will starting sometime in August imho, without additional positive news. I happen to think mnkd will have some positive news by then but unfortunatley I am not expecting any enhancements to the reoccuring revenue that is so far only coming in through sales of Afrezza. My goal is by mid 2021 for possible break even.
|
|
|
Post by buyitonsale on Apr 15, 2019 16:24:23 GMT -5
Cannot make ANVISA move faster.
Cannot make UTHR make a decision about second molecule faster.
Cannot control potential pipeline partners to commit faster or make RLS wake up.
Let’s hear a specific example of management dropping the ball with regards to 1H catalysts,
|
|
|
Post by awesomo on Apr 15, 2019 16:33:49 GMT -5
Cannot make ANVISA move faster. Cannot make UTHR make a decision about second molecule faster. Cannot control potential pipeline partners to commit faster or make RLS wake up. Let’s hear a specific example of management dropping the ball with regards to 1H catalysts, - Script growth
- TV campaign
- Lack of social media presence still
- Pulling out of the biggest diabetes conference
- Mike continuing his fundraising tour
- Asking for raises while shareholder value erodes
- Lack of accountability
- Very poor investor relations
|
|
|
Post by buyitonsale on Apr 15, 2019 16:46:52 GMT -5
Above list has no affect on 1H catalysts that are expected by the market.
|
|
|
Post by awesomo on Apr 15, 2019 16:55:36 GMT -5
Above list has no affect on 1H catalysts that are expected by the market. LOL, wow. OK, list the positives that MannKind has done so far this year in regards to 1H catalysts.
|
|
|
Post by sportsrancho on Apr 15, 2019 18:08:58 GMT -5
Where can one learn about MNKD as a potential investment? Well, the NASDAQ website is logical place to start. And on there you just look under Fundamentals, click on Call Transcripts. From there just click on Summary and.....oh look! Check out all the Osborne negative articles about MNKD. How convenient! Right exactly, I’d never buy the stock, and I search for a lot of stocks but it’s portrayed as too risky an investment to jump into, just about everywhere on every stock app I have. You have to have something that turns the sentiment around. When companies are doing well everybody’s happy, and you can feel that in the articles and the tweets around that stock. Sure there’s an article that comes out every once in a while that tries to de-rail everyone and throw everyone off track but most of them should be positive. We have no analyst coverage we have no positive upbeat articles that come out every week. PR department needs to generate anticipation and excitement.
|
|
|
Post by bones1026 on Apr 15, 2019 18:35:50 GMT -5
Duhhh! Don’t you think it’s a bit difficult to execute properly and do what’s needed to grow when the share price is consistently manipulated down?!!! Absolutely amazes me that there are people here that think SO is just a guy with a weird hobby. This guy has been formulating these articles (as you mentioned, there are many brains contributing to these articles, he’s not doing this all on his own) for years. It absolutely is his FULL TIME ‘job’ And no, his articles are not causing anyone here to buy or sell, that’s because we have seen these for years...but you can bet there are others who may be thinking about investing, begin their due diligence by googling MNKD, and guess what they all see...negative article after negative article by SO, who they think must be reputable, since he is getting all these articles published, not knowing that Seeking Alpha is basically a journalism ‘chop shop’ Before everyone jumps in with “he is not hindering doctors from prescribing Afrezza”....I realize that...but him, AF and all the others, have always made me feel like I’ve been partially cheated out of my investment...and honestly, I’m tired of it
|
|